In terms of methylation and copy number profile, as well as histological appearance and molecular signature, a novel IDH1-WT GBM methylation subgroup that differs from previously reported molecular subgroups was recently introduced in the classification of glioma (44). Here, IDH1 is linked to central nervous system cancer.